Pallawi Torka Selected Research

Pallawi Torka Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 02/2018
5	Lymphoma (Lymphomas) 12/2022 - 01/2020
4	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2020
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2020 - 01/2018
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2020 - 01/2020
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2020 - 01/2019
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 01/2018
2	COVID-19 01/2022 - 01/2021
1	Herpes Zoster 12/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022
1	Disease Progression 01/2022
1	Residual Neoplasm 01/2022
1	Multiple Myeloma 01/2022
1	Lymphadenopathy 11/2020
1	Guillain-Barre Syndrome 05/2020
1	Skin Diseases (Skin Disease) 05/2020
1	Cholestasis 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Thrombocytopenia (Thrombopenia) 10/2019
1	Hematologic Neoplasms (Hematological Malignancy) 10/2019
1	Extranodal NK-T-Cell Lymphoma 02/2018
1	Postmenopausal Osteoporosis 01/2017
1	Acute Promyelocytic Leukemia 01/2016
1	Fever (Fevers) 06/2013
1	Intravenous Substance Abuse 06/2013
1	Poisoning 06/2009
1	Hypokalemia 06/2009
1	Quadriplegia (Spastic Quadriplegia) 06/2009

Drug/Important Bio-Agent (IBA)

5	Rituximab (Mabthera)FDA Link 12/2022 - 01/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2020
2	ibrutinibIBA 01/2022 - 01/2019
2	Biological ProductsIBA 07/2020 - 10/2019
2	venetoclaxIBA 05/2020 - 01/2020
1	Bendamustine Hydrochloride FDA Link 12/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	ofatumumab FDA Link 01/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	Lenalidomide (CC 5013)FDA Link 01/2022
1	AnthracyclinesIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2022
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022
1	EnzymesIBA 07/2020
1	pevonedistatIBA 07/2020
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 07/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	tributyl phosphate (TBP)IBA 01/2020
1	PlatinumIBA 01/2020
1	plerixafor FDA Link 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Ifosfamide FDA LinkGeneric 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2019
1	Monoclonal AntibodiesIBA 10/2019
1	pegfilgrastim (Neulasta)FDA Link 01/2018
1	romosozumabIBA 01/2017
1	Arsenic Trioxide (Trisenox)FDA Link 01/2016
1	Heroin (Diamorphine)IBA 06/2013
1	RodenticidesIBA 06/2009
1	PotassiumIBA 06/2009
1	BariumIBA 06/2009
1	barium carbonateIBA 06/2009

Therapy/Procedure

13	Therapeutics 12/2022 - 01/2016
4	Drug Therapy (Chemotherapy) 11/2020 - 01/2020
2	Stem Cell Transplantation 01/2022 - 01/2020
2	Immunotherapy 05/2020 - 01/2020
1	Transplantation 01/2022
1	Drug Tapering 01/2019